In March 2025, the company announced new plans to get a direct-to-purchaser supplying of its Wegovy weight loss drug. The company founded a whole new pharmacy, known as NovoCare, which might cost buyers $499 a month for access to the drug, under half the price of the drug as a result of other pharmaceutical distribution networks.[53]This led Novo N